Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2490964 | chr13:114159903 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2490965 | chr13:114160392 | T/G | 4.56E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490966 | chr13:114160439 | G/A | 4.56E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490967 | chr13:114161382 | C/T | 3.87E-12 | 178 | 3.32 | 29.5 | 24.17 | KM Plot |
PCPG | rs2490968 | chr13:114162283 | G/C | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2490969 | chr13:114162310 | A/G | 3.87E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490970 | chr13:114162347 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490972 | chr13:114163848 | A/G | 5.41E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2490973 | chr13:114163986 | C/T | 3.87E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2490974 | chr13:114164031 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490975 | chr13:114164277 | C/T | 3.87E-12 | 178 | 3.32 | 29.95 | 24.17 | KM Plot |
PCPG | rs2490976 | chr13:114164380 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490977 | chr13:114164401 | G/C | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2490978 | chr13:114164410 | A/G | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2490979 | chr13:114166070 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |